CLEC1B and neoplasm: For example, ADAM9 was identified as a counter receptor for platelet integrin α6β1 on two different types of mouse tumor cells [56], and galectin-3 and podoplanin as counter-receptors for platelet glycoprotein VI (GPVI) [57] and CLEC-2 [58], respectively.